特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
960607

急性冠症候群治療の世界市場 - 2025年までの予測:タイプ・薬剤・治療法・診断・エンドユーザー別、COVID-19の累積的影響

Acute Coronary Syndrome Therapeutic Market Research Report by Type, by Drug, by Treatment, by Diagnosis, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 175 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
急性冠症候群治療の世界市場 - 2025年までの予測:タイプ・薬剤・治療法・診断・エンドユーザー別、COVID-19の累積的影響
出版日: 2020年09月15日
発行: 360iResearch LLP
ページ情報: 英文 175 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界における急性冠症候群治療の市場規模は、2019年の71億8568万米ドルから、2025年末までに102億5745万米ドルへ拡大すると予測され、6.11%のCAGRが見込まれています。

当レポートでは、世界の急性冠症候群治療市場について取り上げ、市場ダイナミクス、競合環境、各セグメント・地域別の市場、競合状況、および主要企業などについて詳細に分析しています。

第1章 序文

  • 調査の目的
  • 市場セグメンテーションとカバレッジ
  • 調査対象年度
  • 通貨と価格
  • 言語
  • ステークホルダー

第2章 調査手法

  • 調査プロセス
    • 定義: 調査目的
    • 決定: 調査設計
    • 準備: 調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 発行: 調査報告書
    • 繰り返し:レポートの更新
  • 調査実施
    • 開始: 調査プロセス
    • 計画: 調査計画の策定
    • 実行: 調査の実施
    • 検証:検索と分析
    • 出版物: 調査報告
  • 調査結果

第3章 エグゼクティブサマリー

  • イントロダクション
  • 市場の展望
  • 薬剤の展望
  • タイプの展望
  • 治療法の展望
  • 診断の展望
  • エンドユーザーの展望
  • 地域の展望
  • 競合企業の展望

第4章 市場概要

  • イントロダクション

第5章 市場力学

  • イントロダクション
  • 促進要因
    • アテローム性動脈硬化症(心筋梗塞)および不安定狭心症の症例が増加
    • 人口増加と免疫システムの低下
    • 医薬品の研究開発投資の増加と革新的な医薬品の投入
  • 抑制要因
    • 急性冠症候群の治療用に認可された医薬品の数が少ないことによる抑制
  • 市場機会
    • 患者の生存を促進するための心筋の再灌流と再梗塞の防止
    • 高い患者コンプライアンスや安全性の向上などの特性を持つ広範なパイプライン薬
    • 医療インフラストラクチャと政府の医療費償還プログラムの改善
  • 課題
    • コストおよび処方

第6章 市場考察

  • ポーターのファイブフォース分析
  • COVID-19の累積的影響
  • クライアントのカスタマイズ

第7章 世界の急性冠症候群治療市場:タイプ別

  • イントロダクション
  • 非ST上昇型心筋梗塞
  • ST上昇型心筋梗塞
  • バイアル不安定狭心症

第8章 世界の急性冠症候群治療市場:薬剤別

  • イントロダクション
  • 降圧薬
  • 抗血栓薬
  • スタチン

第9章 世界の急性冠症候群治療市場:治療法別

  • イントロダクション
  • 薬物治療
    • 抗狭心症薬
    • 抗凝固剤
    • 抗血小板薬
  • 退院後の治療
  • プレホスピタルケア
  • 再灌流療法

第10章 世界の急性冠症候群治療市場:診断法別

  • イントロダクション
  • 血液検査
  • コンピュータ断層撮影血管造影
  • 冠動脈造影
  • 心エコー図
  • イメージング

第11章 世界の急性冠症候群治療市場:エンドユーザー別

  • イントロダクション
  • 学術機関
  • 診断センター
  • 病院&クリニック

第12章 急性冠症候群治療市場:南北アメリカ

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第13章 急性冠症候群治療市場:アジア太平洋

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第14章 急性冠症候群治療市場:欧州、中東およびアフリカ

  • イントロダクション
  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第15章 競合情勢

  • FPNVポジショニングマトリックス
  • 市場ランキング分析
  • 市場シェア分析
  • 競合シナリオ

第16章 企業ユーザビリティプロファイル

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Baxter International Inc.
  • Bayer AG
  • Beijing Minhai Biotechnology Co., Ltd.
  • Biogen Inc.
  • Boehringer Ingelheim International GmbH
  • 第一三共
  • Eli Lilly and Company
  • Gilead Sciences, Inc.,
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.,
  • Novartis International AG
  • Pfizer Inc.
  • Portola Pharmaceuticals
  • Regeneron Pharmaceuticals, Inc.
  • Resverlogix Corp.
  • Sanofi S.A
  • Serum Institute of India
  • Teva Pharmaceutical Industries Ltd.

第17章 付録

  • ディスカッションガイド
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: RESEARCH EXECUTION
  • FIGURE 3. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, 2019 VS 2025 (USD MILLION)
  • FIGURE 4. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2019 VS 2025 (USD MILLION)
  • FIGURE 5. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2019 VS 2025 (USD MILLION)
  • FIGURE 6. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2019 VS 2025 (USD MILLION)
  • FIGURE 7. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2019 VS 2025 (USD MILLION)
  • FIGURE 8. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2019 VS 2025 (USD MILLION)
  • FIGURE 9. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  • FIGURE 10. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, 2017-2025 (USD MILLION)
  • FIGURE 11. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
  • FIGURE 12. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  • FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 14. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: MARKET DYNAMICS
  • FIGURE 15. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 16. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2019 VS 2025 (%)
  • FIGURE 17. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2019 VS 2025 (USD MILLION)
  • FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2025
  • FIGURE 19. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY NON-ST-ELEVATION MYOCARDIAL INFARCTION, 2019 VS 2025 (USD MILLION)
  • FIGURE 20. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ST-ELEVATION MYOCARDIAL INFARCTION, 2019 VS 2025 (USD MILLION)
  • FIGURE 21. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY VIAL UNSTABLE ANGINA, 2019 VS 2025 (USD MILLION)
  • FIGURE 22. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2019 VS 2025 (%)
  • FIGURE 23. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2019 VS 2025 (USD MILLION)
  • FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2025
  • FIGURE 25. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTIHYPERTENSIVE, 2019 VS 2025 (USD MILLION)
  • FIGURE 26. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTITHROMBOTIC, 2019 VS 2025 (USD MILLION)
  • FIGURE 27. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY STATINS, 2019 VS 2025 (USD MILLION)
  • FIGURE 28. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2019 VS 2025 (%)
  • FIGURE 29. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2019 VS 2025 (USD MILLION)
  • FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2025
  • FIGURE 31. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG TREATMENT, 2019 VS 2025 (USD MILLION)
  • FIGURE 32. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTIANGINAL DRUG, 2019 VS 2025 (USD MILLION)
  • FIGURE 33. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTICOAGULANT, 2019 VS 2025 (USD MILLION)
  • FIGURE 34. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTIPLATELET DRUG, 2019 VS 2025 (USD MILLION)
  • FIGURE 35. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY POST DISCHARGE TREATMENT, 2019 VS 2025 (USD MILLION)
  • FIGURE 36. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY PREHOSPITAL CARE, 2019 VS 2025 (USD MILLION)
  • FIGURE 37. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY REPERFUSION THERAPY, 2019 VS 2025 (USD MILLION)
  • FIGURE 38. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2019 VS 2025 (%)
  • FIGURE 39. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2019 VS 2025 (USD MILLION)
  • FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2025
  • FIGURE 41. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY BLOOD TESTS, 2019 VS 2025 (USD MILLION)
  • FIGURE 42. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY ANGIOGRAM, 2019 VS 2025 (USD MILLION)
  • FIGURE 43. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY CORONARY ANGIOGRAM, 2019 VS 2025 (USD MILLION)
  • FIGURE 44. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ECHOCARDIOGRAM, 2019 VS 2025 (USD MILLION)
  • FIGURE 45. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY IMAGING, 2019 VS 2025 (USD MILLION)
  • FIGURE 46. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2019 VS 2025 (%)
  • FIGURE 47. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2019 VS 2025 (USD MILLION)
  • FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2025
  • FIGURE 49. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ACADEMIC INSTITUTES, 2019 VS 2025 (USD MILLION)
  • FIGURE 50. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSTIC CENTERS, 2019 VS 2025 (USD MILLION)
  • FIGURE 51. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY HOSPITAL & CLINICS, 2019 VS 2025 (USD MILLION)
  • FIGURE 52. AMERICAS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
  • FIGURE 53. AMERICAS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  • FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 55. ARGENTINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 56. BRAZIL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 57. CANADA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 58. MEXICO ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 59. UNITED STATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 60. ASIA-PACIFIC ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
  • FIGURE 61. ASIA-PACIFIC ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  • FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 63. AUSTRALIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 64. CHINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 65. INDIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 66. INDONESIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 67. JAPAN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 68. MALAYSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 69. PHILIPPINES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 70. SOUTH KOREA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 71. THAILAND ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 72. EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
  • FIGURE 73. EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  • FIGURE 74. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 75. FRANCE ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 76. GERMANY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 77. ITALY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 78. NETHERLANDS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 79. QATAR ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 80. RUSSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 81. SAUDI ARABIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 82. SOUTH AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 83. SPAIN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 84. UNITED ARAB EMIRATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 85. UNITED KINGDOM ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 86. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
  • FIGURE 87. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
  • FIGURE 88. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, 2017-2025 (USD MILLION)
  • TABLE 2. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 3. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 4. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY NON-ST-ELEVATION MYOCARDIAL INFARCTION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 5. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ST-ELEVATION MYOCARDIAL INFARCTION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 6. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY VIAL UNSTABLE ANGINA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 7. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 8. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTIHYPERTENSIVE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 9. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTITHROMBOTIC, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 10. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY STATINS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 11. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 12. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG TREATMENT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 13. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTIANGINAL DRUG, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 14. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTICOAGULANT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 15. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ANTIPLATELET DRUG, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 16. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY POST DISCHARGE TREATMENT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 17. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY PREHOSPITAL CARE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 18. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY REPERFUSION THERAPY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 19. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 20. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY BLOOD TESTS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 21. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY ANGIOGRAM, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 22. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY CORONARY ANGIOGRAM, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 23. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ECHOCARDIOGRAM, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 24. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY IMAGING, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 25. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 26. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY ACADEMIC INSTITUTES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 27. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 28. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY HOSPITAL & CLINICS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 29. AMERICAS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 30. AMERICAS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 31. AMERICAS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 32. AMERICAS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 33. AMERICAS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 34. AMERICAS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 35. ARGENTINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 36. ARGENTINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 37. ARGENTINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 38. ARGENTINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 39. ARGENTINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 40. BRAZIL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 41. BRAZIL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 42. BRAZIL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 43. BRAZIL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 44. BRAZIL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 45. CANADA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 46. CANADA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 47. CANADA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 48. CANADA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 49. CANADA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 50. MEXICO ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 51. MEXICO ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 52. MEXICO ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 53. MEXICO ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 54. MEXICO ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 55. UNITED STATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 56. UNITED STATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 57. UNITED STATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 58. UNITED STATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 59. UNITED STATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 66. AUSTRALIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 67. AUSTRALIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 68. AUSTRALIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 69. AUSTRALIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 70. AUSTRALIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 71. CHINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 72. CHINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 73. CHINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 74. CHINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 75. CHINA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 76. INDIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 77. INDIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 78. INDIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 79. INDIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 80. INDIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 81. INDONESIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 82. INDONESIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 83. INDONESIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 84. INDONESIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 85. INDONESIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 86. JAPAN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 87. JAPAN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 88. JAPAN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 89. JAPAN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 90. JAPAN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 91. MALAYSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 92. MALAYSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 93. MALAYSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 94. MALAYSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 95. MALAYSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 96. PHILIPPINES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 97. PHILIPPINES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 98. PHILIPPINES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 99. PHILIPPINES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 100. PHILIPPINES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 101. SOUTH KOREA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 102. SOUTH KOREA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 103. SOUTH KOREA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 104. SOUTH KOREA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 105. SOUTH KOREA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 106. THAILAND ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 107. THAILAND ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 108. THAILAND ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 109. THAILAND ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 110. THAILAND ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 117. FRANCE ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 118. FRANCE ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 119. FRANCE ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 120. FRANCE ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 121. FRANCE ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 122. GERMANY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 123. GERMANY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 124. GERMANY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 125. GERMANY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 126. GERMANY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 127. ITALY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 128. ITALY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 129. ITALY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 130. ITALY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 131. ITALY ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 132. NETHERLANDS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 133. NETHERLANDS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 134. NETHERLANDS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 135. NETHERLANDS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 136. NETHERLANDS ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 137. QATAR ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 138. QATAR ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 139. QATAR ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 140. QATAR ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 141. QATAR ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 142. RUSSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 143. RUSSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 144. RUSSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 145. RUSSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 146. RUSSIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 147. SAUDI ARABIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 148. SAUDI ARABIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 149. SAUDI ARABIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 150. SAUDI ARABIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 151. SAUDI ARABIA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 152. SOUTH AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 153. SOUTH AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 154. SOUTH AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 155. SOUTH AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 156. SOUTH AFRICA ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 157. SPAIN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 158. SPAIN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 159. SPAIN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 160. SPAIN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 161. SPAIN ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 162. UNITED ARAB EMIRATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 163. UNITED ARAB EMIRATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 164. UNITED ARAB EMIRATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 165. UNITED ARAB EMIRATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 166. UNITED ARAB EMIRATES ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 167. UNITED KINGDOM ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DRUG, 2017-2025 (USD MILLION)
  • TABLE 168. UNITED KINGDOM ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 169. UNITED KINGDOM ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
  • TABLE 170. UNITED KINGDOM ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY DIAGNOSIS, 2017-2025 (USD MILLION)
  • TABLE 171. UNITED KINGDOM ACUTE CORONARY SYNDROME THERAPEUTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 172. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: SCORES
  • TABLE 173. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: BUSINESS STRATEGY
  • TABLE 174. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: PRODUCT SATISFACTION
  • TABLE 175. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: RANKING
  • TABLE 176. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: MERGER & ACQUISITION
  • TABLE 177. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 178. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 179. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: INVESTMENT & FUNDING
  • TABLE 180. GLOBAL ACUTE CORONARY SYNDROME THERAPEUTIC MARKET: AWARD, RECOGNITION, & EXPANSION
目次
Product Code: MRR-E4D9530

Title:
Acute Coronary Syndrome Therapeutic Market Research Report by Type (Non-ST-elevation Myocardial Infarction, ST-elevation Myocardial Infarction, and Vial Unstable Angina), by Drug (Antihypertensive, Antithrombotic, and Statins), by Treatment, by Diagnosis, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19.

The Global Acute Coronary Syndrome Therapeutic Market is expected to grow from USD 7,185.68 Million in 2019 to USD 10,257.45 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.11%.

Market Segmentation & Coverage:

This research report categorizes the Acute Coronary Syndrome Therapeutic to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the Acute Coronary Syndrome Therapeutic Market studied across Non-ST-elevation Myocardial Infarction, ST-elevation Myocardial Infarction, and Vial Unstable Angina.

Based on Drug, the Acute Coronary Syndrome Therapeutic Market studied across Antihypertensive, Antithrombotic, and Statins.

Based on Treatment, the Acute Coronary Syndrome Therapeutic Market studied across Drug Treatment, Post Discharge Treatment, Prehospital Care, and Reperfusion Therapy. The Drug Treatment further studied across Antianginal Drug, Anticoagulant, and Antiplatelet Drug.

Based on Diagnosis, the Acute Coronary Syndrome Therapeutic Market studied across Blood Tests, Computerized Tomography Angiogram, Coronary Angiogram, Echocardiogram, and Imaging.

Based on End User, the Acute Coronary Syndrome Therapeutic Market studied across Academic Institutes, Diagnostic Centers, and Hospital & Clinics.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Acute Coronary Syndrome Therapeutic Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Acute Coronary Syndrome Therapeutic Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Acute Coronary Syndrome Therapeutic Market including AbbVie Inc., Amgen Inc., AstraZeneca PLC, Baxter International Inc., Bayer AG, Beijing Minhai Biotechnology Co., Ltd., Biogen Inc., Boehringer Ingelheim International GmbH, Daiichi Sankyo Company, Limited., Eli Lilly and Company, Gilead Sciences, Inc.,, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc.,, Novartis International AG, Pfizer Inc., Portola Pharmaceuticals, Regeneron Pharmaceuticals, Inc., Resverlogix Corp., Sanofi S.A, Serum Institute of India, and Teva Pharmaceutical Industries Ltd..

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Acute Coronary Syndrome Therapeutic Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Acute Coronary Syndrome Therapeutic Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Acute Coronary Syndrome Therapeutic Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Acute Coronary Syndrome Therapeutic Market?
  • 4. What is the competitive strategic window for opportunities in the Global Acute Coronary Syndrome Therapeutic Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Acute Coronary Syndrome Therapeutic Market?
  • 6. What are the modes and strategic moves considered suitable for entering the Global Acute Coronary Syndrome Therapeutic Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Define: Research Objective
    • 2.1.2. Determine: Research Design
    • 2.1.3. Prepare: Research Instrument
    • 2.1.4. Collect: Data Source
    • 2.1.5. Analyze: Data Interpretation
    • 2.1.6. Formulate: Data Verification
    • 2.1.7. Publish: Research Report
    • 2.1.8. Repeat: Report Update
  • 2.2. Research Execution
    • 2.2.1. Initiation: Research Process
    • 2.2.2. Planning: Develop Research Plan
    • 2.2.3. Execution: Conduct Research
    • 2.2.4. Verification: Finding & Analysis
    • 2.2.5. Publication: Research Report
  • 2.3. Research Outcome

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Drug Outlook
  • 3.4. Type Outlook
  • 3.5. Treatment Outlook
  • 3.6. Diagnosis Outlook
  • 3.7. End User Outlook
  • 3.8. Geography Outlook
  • 3.9. Competitor Outlook

4. Market Overview

  • 4.1. Introduction

5. Market Dynamics

  • 5.1. Introduction
  • 5.2. Drivers
    • 5.2.1. Increased cases of atherosclerosis (myocardial infarction) and unstable angina
    • 5.2.2. Growing aging population and poor immune systems
    • 5.2.3. Increased pharmaceutical R&D investment and introduction of innovative drugs
  • 5.3. Restraints
    • 5.3.1. Obstruction due to less number of approved drugs for the treatment of acute coronary syndrome
  • 5.4. Opportunities
    • 5.4.1. Reperfusion of the myocardium and prevent reinfarction in order to promote patient survival
    • 5.4.2. Extensive pipeline drugs with properties, such as high patient compliance and improved safety
    • 5.4.3. Improving health care infrastructure and government reimbursement programs
  • 5.5. Challenges
    • 5.5.1. Cost and formulation

6. Market Insights

  • 6.1. Porters Five Forces Analysis
    • 6.1.1. Threat of New Entrants
    • 6.1.2. Threat of Substitutes
    • 6.1.3. Bargaining Power of Customers
    • 6.1.4. Bargaining Power of Suppliers
    • 6.1.5. Industry Rivalry
  • 6.2. Cumulative Impact of COVID-19
  • 6.3. Client Customizations

7. Global Acute Coronary Syndrome Therapeutic Market, By Type

  • 7.1. Introduction
  • 7.2. Non-ST-elevation Myocardial Infarction
  • 7.3. ST-elevation Myocardial Infarction
  • 7.4. Vial Unstable Angina

8. Global Acute Coronary Syndrome Therapeutic Market, By Drug

  • 8.1. Introduction
  • 8.2. Antihypertensive
  • 8.3. Antithrombotic
  • 8.4. Statins

9. Global Acute Coronary Syndrome Therapeutic Market, By Treatment

  • 9.1. Introduction
  • 9.2. Drug Treatment
    • 9.2.1. Antianginal Drug
    • 9.2.2. Anticoagulant
    • 9.2.3. Antiplatelet Drug
  • 9.3. Post Discharge Treatment
  • 9.4. Prehospital Care
  • 9.5. Reperfusion Therapy

10. Global Acute Coronary Syndrome Therapeutic Market, By Diagnosis

  • 10.1. Introduction
  • 10.2. Blood Tests
  • 10.3. Computerized Tomography Angiogram
  • 10.4. Coronary Angiogram
  • 10.5. Echocardiogram
  • 10.6. Imaging

11. Global Acute Coronary Syndrome Therapeutic Market, By End User

  • 11.1. Introduction
  • 11.2. Academic Institutes
  • 11.3. Diagnostic Centers
  • 11.4. Hospital & Clinics

12. Americas Acute Coronary Syndrome Therapeutic Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Acute Coronary Syndrome Therapeutic Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. South Korea
  • 13.10. Thailand

14. Europe, Middle East & Africa Acute Coronary Syndrome Therapeutic Market

  • 14.1. Introduction
  • 14.2. France
  • 14.3. Germany
  • 14.4. Italy
  • 14.5. Netherlands
  • 14.6. Qatar
  • 14.7. Russia
  • 14.8. Saudi Arabia
  • 14.9. South Africa
  • 14.10. Spain
  • 14.11. United Arab Emirates
  • 14.12. United Kingdom

15. Competitive Landscape

  • 15.1. FPNV Positioning Matrix
    • 15.1.1. Quadrants
    • 15.1.2. Business Strategy
    • 15.1.3. Product Satisfaction
  • 15.2. Market Ranking Analysis
  • 15.3. Market Share Analysis
  • 15.4. Competitive Scenario
    • 15.4.1. Merger & Acquisition
    • 15.4.2. Agreement, Collaboration, & Partnership
    • 15.4.3. New Product Launch & Enhancement
    • 15.4.4. Investment & Funding
    • 15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles

  • 16.1. AbbVie Inc.
  • 16.2. Amgen Inc.
  • 16.3. AstraZeneca PLC
  • 16.4. Baxter International Inc.
  • 16.5. Bayer AG
  • 16.6. Beijing Minhai Biotechnology Co., Ltd.
  • 16.7. Biogen Inc.
  • 16.8. Boehringer Ingelheim International GmbH
  • 16.9. Daiichi Sankyo Company, Limited.
  • 16.10. Eli Lilly and Company
  • 16.11. Gilead Sciences, Inc.,
  • 16.12. GlaxoSmithKline plc
  • 16.13. Johnson & Johnson Services, Inc.
  • 16.14. Merck & Co., Inc.,
  • 16.15. Novartis International AG
  • 16.16. Pfizer Inc.
  • 16.17. Portola Pharmaceuticals
  • 16.18. Regeneron Pharmaceuticals, Inc.
  • 16.19. Resverlogix Corp.
  • 16.20. Sanofi S.A
  • 16.21. Serum Institute of India
  • 16.22. Teva Pharmaceutical Industries Ltd.

17. Appendix

  • 17.1. Discussion Guide
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.